Progenics Pharma (PGNX), Salix Pharma (SLXP) Receive Response from FDA on RELISTOR sNDA as OIC Treatment
Tweet Send to a Friend
Salix Pharmaceuticals, Ltd. (Nasaq: SLXP) and Progenics Pharmaceuticals (Nasdaq: PGNX) announced that the Food and Drug Administration (FDA or Agency) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE